WuXi AppTec plans capital expenditure increase of at least 17% in 2026
The CRDMO is adding new drug substance and drug product manufacturing capacity in Asia, Europe, and the U.S. — including a 1.74 million-square-foot plant in Delaware.
Read the full article on the original site.
Read Full Article